AIMC Topic: Lactulose

Clear Filters Showing 1 to 5 of 5 articles

Artificial Intelligence-Enabled Stool Analysis for Lactulose Titration Assistance in Hepatic Encephalopathy Through a Smartphone Application.

The American journal of gastroenterology Jan 19, 2024
INTRODUCTION: Management of hepatic encephalopathy relies on self-titration of lactulose. In this feasibility trial, we assess an artificial intelligence-enabled tool to guide lactulose use through a smartphone application.
Humans Aged Male Middle Aged Artificial Intelligence Female Feasibility Studies Hepatic Encephalopathy Lactulose Mobile Applications Gastrointestinal Agents Feces Smartphone
View on PubMed DOI

Artificial Intelligence Evaluation of Stool Quality Guides Management of Hepatic Encephalopathy Using a Smartphone App.

The American journal of gastroenterology Dec 28, 2023
Lactulose-based hepatic encephalopathy treatment requires bowel movements/day titration, which is improved with Bristol stool scale (BSS) incorporation. Dieta app evaluates artificial intelligence (AI)-based BSS (AI-BSS) with stool images. Initially,...
Hepatic Encephalopathy Lactulose Liver Cirrhosis Gastrointestinal Agents Aged Adult Artificial Intelligence Female Humans Male Middle Aged Smartphone Mobile Applications Feces
View on PubMed DOI

Assessment of the pharmacokinetics, removal rate of hemodialysis, and safety of lactulose in hemodialysis patients.

Journal of food and drug analysis Aug 29, 2016
Lactulose is often used to treat hepatic encephalopathy or constipation, and also exhibits benefits to chronic renal insufficiency due to reduce nitrogen-related products in serum. The present study investigated the pharmacokinetics of lactulose, its...
Lactulose Renal Insufficiency, Chronic Humans Taiwan Renal Dialysis
View on PubMed DOI

The machine learning prediction model of non-alcoholic fatty liver; the role of hydrogen and methane breath tests.

Journal of breath research Jun 13, 2025
Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of global chronic liver disease, affecting approximately 32.4% of the population in various regions and imposing healthcare and economic burdens. The gold standard for the diagnosis of...
Male Middle Aged ROC Curve Female Adult Humans Hydrogen Machine Learning Breath Tests Lactulose Methane Non-alcoholic Fatty Liver Disease
View on PubMed DOI

Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.

The American journal of gastroenterology Feb 1, 2021
INTRODUCTION: Readmission and death in cirrhosis are common, expensive, and difficult to predict. Our aim was to evaluate the abilities of multiple artificial intelligence (AI) techniques to predict clinical outcomes based on variables collected at a...
Water-Electrolyte Imbalance Male Patient Readmission Middle Aged Proton Pump Inhibitors Severity of Illness Index Adrenergic beta-Antagonists Reproducibility of Results Mortality Clinical Decision Rules Aged Lactulose Rifaximin Logistic Models beta-Lactams Liver Cirrhosis Hepatic Encephalopathy End Stage Liver Disease Support Vector Machine Infections Paracentesis Ascites Cohort Studies Gastrointestinal Hemorrhage Kidney Diseases ROC Curve Gastrointestinal Agents Hydrothorax Humans Anti-Bacterial Agents Machine Learning Female
View on PubMed DOI
Popular Topics
Recent Journals